UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 103 filers reported holding UROGEN PHARMA LTD in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $539,385 | +38.1% | 38,500 | +2.0% | 0.14% | +51.0% |
| Q2 2023 | $390,526 | +14.2% | 37,732 | +2.0% | 0.10% | +11.6% |
| Q1 2023 | $341,880 | +4.2% | 37,000 | 0.0% | 0.09% | -7.5% |
| Q4 2022 | $328,190 | +6.6% | 37,000 | 0.0% | 0.09% | +12.0% |
| Q3 2022 | $308,000 | +1.7% | 37,000 | 0.0% | 0.08% | -10.8% |
| Q2 2022 | $303,000 | -8.5% | 37,000 | -2.6% | 0.09% | +22.4% |
| Q1 2022 | $331,000 | -67.5% | 38,000 | -48.6% | 0.08% | -64.2% |
| Q4 2021 | $1,019,000 | +63.8% | 74,000 | +100.0% | 0.21% | +47.2% |
| Q3 2021 | $622,000 | +10.1% | 37,000 | 0.0% | 0.14% | +24.1% |
| Q2 2021 | $565,000 | -21.6% | 37,000 | 0.0% | 0.12% | -12.1% |
| Q1 2021 | $721,000 | +8.1% | 37,000 | 0.0% | 0.13% | 0.0% |
| Q4 2020 | $667,000 | -6.6% | 37,000 | 0.0% | 0.13% | -39.4% |
| Q3 2020 | $714,000 | -26.1% | 37,000 | 0.0% | 0.22% | -29.2% |
| Q2 2020 | $966,000 | +46.4% | 37,000 | 0.0% | 0.31% | +27.3% |
| Q1 2020 | $660,000 | +0.5% | 37,000 | +87.9% | 0.24% | +41.5% |
| Q4 2019 | $657,000 | +40.1% | 19,692 | +11.3% | 0.17% | +6.9% |
| Q3 2019 | $469,000 | -26.3% | 17,692 | 0.0% | 0.16% | -14.9% |
| Q2 2019 | $636,000 | +72.4% | 17,692 | +76.9% | 0.19% | +45.7% |
| Q1 2019 | $369,000 | -61.4% | 10,000 | -48.0% | 0.13% | -66.5% |
| Q2 2018 | $957,000 | +0.1% | 19,230 | 0.0% | 0.38% | +11.0% |
| Q1 2018 | $956,000 | -35.7% | 19,230 | -50.0% | 0.35% | -26.9% |
| Q4 2017 | $1,486,000 | +22.6% | 38,461 | 0.0% | 0.48% | +19.6% |
| Q3 2017 | $1,212,000 | +74.4% | 38,461 | 0.0% | 0.40% | +69.7% |
| Q2 2017 | $695,000 | – | 38,461 | – | 0.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |